Total Assets (Quarterly) Chart

Historical Total Assets (Quarterly) Data

View and export this data back to 2002. Start Trial.
Date Value
September 30, 2015 1.010M
June 30, 2015 1.050M
March 31, 2015 0.988M
December 31, 2014 1.000M
September 30, 2014 1.104M
June 30, 2014 1.227M
March 31, 2014 1.654M
December 31, 2013 1.538M
September 30, 2013 0.8348M
June 30, 2013 0.5985M
March 31, 2013 0.4524M
December 31, 2012 0.5657M
September 30, 2012 0.6021M
June 30, 2012 0.5024M
March 31, 2012 0.4364M
December 31, 2011 0.496M
September 30, 2011 0.5028M
June 30, 2011 0.4944M
March 31, 2011 0.5113M
December 31, 2010 0.559M
September 30, 2010 0.3968M
June 30, 2010 0.4234M
March 31, 2010 0.5307M
December 31, 2009 0.5138M
September 30, 2009 0.6922M
Date Value
June 30, 2009 0.9588M
March 31, 2009 0.8067M
December 31, 2008 0.9071M
September 30, 2008 1.247M
June 30, 2008 1.070M
March 31, 2008 3.528M
December 31, 2007 1.150M
September 30, 2007 0.9691M
June 30, 2007 0.9791M
March 31, 2007 4.970M
December 31, 2006 5.018M
September 30, 2006 3.032M
June 30, 2006 0.4053M
March 31, 2006 0.3366M
December 31, 2005 0.363M
September 30, 2005 0.4323M
June 30, 2005 0.5725M
March 31, 2005 1.217M
December 31, 2004 0.253M
September 30, 2004 0.8055M
June 30, 2004 0.7118M
March 31, 2004 0.7842M
December 31, 2003 0.8228M
September 30, 2003 1.286M
June 30, 2003 1.114M

Total Assets Definition

Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.

Read full definition.

Total Assets (Quarterly) Range, Past 5 Years

View Total Assets (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Total Assets (Quarterly) Benchmarks

View Total Assets (Quarterly) Benchmarks
Start Trial
Agilent Technologies, Inc. 13.97B
Bio-Rad Laboratories, Inc. 10.25B
Bruker Corp. 6.053B
Danaher Corp. 93.28B
Harvard Bioscience, Inc. 76.29M